Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fangrong Xing
Observed names:
F Xing,
Xing, Fangrong
Institutions:
State Key Laboratory of Synthetic Chemistry,
University of Hong Kong
Observed institutions:
Memorial Sloan Kettering Cancer Center,
State Key Laboratory of Synthetic Chemistry,
University of Hong Kong
ORCID:
0009-0007-2687-002X
Observed ORCID:
0009-0007-2687-002X
OpenAlex ID:
A5000765997
Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF
2011
·
F Xing
, Y Persaud
, et al.
·
Oncogene
·
207
An Antitumor Bis(N‐Heterocyclic Carbene)Platinum(II) Complex That Engages Asparagine Synthetase as an Anticancer Target
2019
·
Di Hu
, Chen Yang
, et al.
·
Angewandte Chemie International Edition
·
57
An Antitumor Bis(N‐Heterocyclic Carbene)Platinum(II) Complex That Engages Asparagine Synthetase as an Anticancer Target
2019
·
Di Hu
, Chen Yang
, et al.
·
Angewandte Chemie
·
37
Direct preparation of unprotected aminimides (R 3 N + –NH − ) from natural aliphatic tertiary alkaloids (R 3 N) by [Mn(TDCPP)Cl]-catalysed N -amination reaction
2020
·
Shilong Zhang
, Yungen Liu
, et al.
·
Chemical Communications
·
10
Integrative chemoproteomics reveals anticancer mechanisms of silver( i ) targeting the proteasome regulatory complex
2024
·
Xiaojian Shao
, Fangrong Xing
, et al.
·
Chemical Science
·
6
PDF
Show more works
View as search
Works count:
6
Citation count:
317
H-index:
5
I10-index:
4
Year
Topic
Type
